Inhibition of Brain Phospholipase A2 by Antimalarial Drugs: Implications for Neuroprotection in Neurological Disorders

Publisher： Bentham Science Publishers

ISSN： 1567-2034

Source： Medicinal Chemistry Reviews - Online, Vol.2, Iss.5, 2005-10, pp. : 379-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection and Drugs Used to Treat Psychiatric Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 12, Iss. 4, 2007-08 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 763-771

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Nucleic Acid Drugs for Neurological Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1621-1629

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 6, 2016-07 ,pp. : 642-643

Bentham Science Publishers

Access to resources Recommend Favorite

Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 21, 2012-11 ,pp. : 2314-2323

Bentham Science Publishers

Access to resources Recommend Favorite